We are live on
!
Find out more
B
Bayban Portfolio holdings
AUM
$130M
This Fund
S&P 500
This Quarter
Est. Return
+2.51%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$113M
AUM Growth
–
Cap. Flow
+$112M
Cap. Flow
% of AUM
99.36%
Top 10 Holdings %
Top 10 Hldgs %
40.85%
Holding
613
New
613
Increased
–
Reduced
–
Closed
–
Avg Time Held
0
quarters
Top 10 Avg Time Held
0
quarters
Top 20 Avg Time Held
0
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$13.8M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$6.06M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$5.15M |
| 4 |
Apple
AAPL
|
+$4.67M |
| 5 |
US Bancorp
USB
|
+$3.94M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.96% |
| 2 | Healthcare | 16.42% |
| 3 | Financials | 11.34% |
| 4 | Technology | 10.67% |
| 5 | Industrials | 5.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
551
Quest Diagnostics
DGX
$25.8B
| $1.74K | ﹤0.01% |
+10
| New | +$1.82K |
2025 Q4
0 quarters
|
|
552
Western Digital
WDC
$150B
| $1.72K | ﹤0.01% |
+10
| New | +$1.52K |
2025 Q4
0 quarters
|
|
553
Aurinia Pharmaceuticals
AUPH
$2.11B
| $1.59K | ﹤0.01% |
+100
| New | +$1.42K |
2025 Q4
0 quarters
|
|
554
Provident Financial
PROV
$114M
| $1.59K | ﹤0.01% |
+100
| New | +$1.56K |
2025 Q4
0 quarters
|
|
555
Warner Bros
WBD
$77.6B
| $1.58K | ﹤0.01% |
+55
| New | +$1.28K |
2025 Q4
0 quarters
|
|
556
AMC Entertainment Holdings
AMC
$2.47B
| $1.56K | ﹤0.01% |
+1,000
| New | +$2.38K |
2025 Q4
0 quarters
|
|
557
Nextpower Inc. Common Stock
NXT
$12.8B
| $1.48K | ﹤0.01% |
+17
| New | +$1.54K |
2025 Q4
0 quarters
|
|
558
iShares Emerging Markets Equity Factor ETF
EMGF
$1.96B
| $1.45K | ﹤0.01% |
+25
| New | +$1.44K |
2025 Q4
0 quarters
|
|
559
BorgWarner
BWA
$12.3B
| $1.4K | ﹤0.01% |
+31
| New | +$1.36K |
2025 Q4
0 quarters
|
|
560
Unity
U
$19.2B
| $1.32K | ﹤0.01% |
+30
| New | +$1.22K |
2025 Q4
0 quarters
|
|
561
Nucor
NUE
$54.5B
| $1.3K | ﹤0.01% |
+8
| New | +$1.2K |
2025 Q4
0 quarters
|
|
|
MGIC
562
DELISTED
Magic Software Enterprises
MGIC
| $1.29K | ﹤0.01% |
+50
| New | +$1.15K |
2025 Q4
0 quarters
|
|
|
FISV
563
Fiserv Inc
FISV
$23.6B
| $1.28K | ﹤0.01% |
+19
| New | +$1.59K |
2025 Q4
0 quarters
|
|
564
Capital One
COF
$119B
| $1.21K | ﹤0.01% |
+5
| New | +$1.11K |
2025 Q4
0 quarters
|
|
565
Dana Inc
DAN
$3B
| $1.19K | ﹤0.01% |
+50
| New | +$1.06K |
2025 Q4
0 quarters
|
|
566
Cemex
CX
$13.8B
| $1.15K | ﹤0.01% |
+100
| New | +$1.03K |
2025 Q4
0 quarters
|
|
567
DexCom
DXCM
$32.2B
| $1.13K | ﹤0.01% |
+17
| New | +$1.1K |
2025 Q4
0 quarters
|
|
568
Diageo
DEO
$47.1B
| $1.12K | ﹤0.01% |
+13
| New | +$1.2K |
2025 Q4
0 quarters
|
|
569
Annaly Capital Management
NLY
$13.9B
| $1.12K | ﹤0.01% |
+50
| New | +$1.09K |
2025 Q4
0 quarters
|
|
570
Associated Banc-Corp
ASB
$5.48B
| $1.08K | ﹤0.01% |
+42
| New | +$1.08K |
2025 Q4
0 quarters
|
|
571
Nutanix
NTNX
$19.6B
| $1.03K | ﹤0.01% |
+20
| New | +$1.22K |
2025 Q4
0 quarters
|
|
572
Freeport-McMoran
FCX
$103B
| $1.02K | ﹤0.01% |
+20
| New | +$867 |
2025 Q4
0 quarters
|
|
|
MICC
573
The Magnum Ice Cream Company N.V.
MICC
$10.6B
| $985 | ﹤0.01% |
+62
| New | +$972 |
2025 Q4
0 quarters
|
|
574
Ericsson
ERIC
$30.3B
| $965 | ﹤0.01% |
+100
| New | +$947 |
2025 Q4
0 quarters
|
|
575
WaFd
WAFD
$2.28B
| $961 | ﹤0.01% |
+30
| New | +$927 |
2025 Q4
0 quarters
|
|
Similar funds
4A
BNA
SCC
HGP
WHC
RHDIC
LIP
PAWC
Bayban's Q4 2025 Portfolio in Review
Q4 2025 is the first quarter with a 13F filing on record for Bayban, which disclosed 613 positions worth $113M. Its ten largest holdings account for 41% of the portfolio.
Its largest position is UnitedHealth: 40,639 shares worth $13.4M.
By sector, the portfolio is most concentrated in Miscellaneous at 40% of assets, followed by Healthcare and Financials.
- Bayban's largest Q4 2025 buy was UnitedHealth: 40,639 shares worth $13.4M.
- Bayban's ten largest holdings make up 41% of its $113M portfolio in Q4 2025.
- Bayban disclosed 613 positions in Q4 2025, its first 13F filing on record.
Based on Bayban's 13F filing for Q4 2025, filed 5 Mar 2026.